![]() |
市场调查报告书
商品编码
1636651
到 2030 年探针再处理市场预测:按产品类型、探针类型、技术、应用、最终用户和地区进行的全球分析Probe Reprocessing Market Forecasts to 2030 - Global Analysis By Product (Reprocessing Systems, Detergents & Disinfectants, Accessories and Other Products), Process Type, Probe Type, Technology, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球探针后处理市场价值为 8.448 亿美元,预计在预测期内将以 12.5% 的复合年增长率增长,到 2030 年将达到 17.126 亿美元。
探头再处理是对诊断影像(例如超音波)中使用的医用探头和换能器进行清洗、消毒和灭菌的过程,以防止交叉污染和医院获得性感染。该过程包括多个步骤,包括手动清洗、高水平消毒和灭菌,具体取决于风险等级。自动化系统通常用于提高效率并确保最佳的感染控制。其目的是确保临床环境中重复使用的医疗探头的安全性和完整性,并受到严格的监管指南和行业标准的约束。
根据 MedStar Health 2024 年 1 月发布的资料,美国每年进行超过 700 万次心臟超音波图。
医院感染增加
医院和诊所感染控制的重点是预防因超音波探头等医疗设备消毒或再处理不当引起的医疗相关感染(HAI)。随着感染风险的增加,医疗机构正在采用专业、可靠、有效的探针再处理技术来确保病患安全。这增加了对先进清洗和消毒系统的需求,推动了探针再处理市场的发展。
缺乏知识和培训
缺乏适当的培训会导致人工清洗错误,导致消毒效率低下和医疗探头供应延误。这可能会扰乱工作流程并增加患者的治疗时间。由于工作流程效率低下,医疗机构可能不愿意投资复杂的后处理系统,从而减少了对先进设备和自动化解决方案的需求。这些系统的复杂性以及训练不足所带来的挑战可能会对采用探针再处理最佳实践产生阻力。
诊断影像的进展
诊断成像探头变得越来越复杂和精密,需要对其功能和精度进行专门维护。这给探针再处理市场带来了越来越大的压力,要求开发能够保持这些设备完整性的解决方案。市场需要专业、先进的后处理设备来处理复杂的清洗过程,需要更好的消毒剂、自动化清洗系统和高水准的消毒解决方案。因此,将需要专业和先进的后製程设备,以满足精密、高科技探针的需求。
自动探针再加工设备高成本
自动化探针再处理系统需要大量初步投资,这对于预算有限的小型医院和医疗中心来说可能是一个挑战。高成本可能会阻碍设施投资这些技术,特别是当资源分配到其他关键领域时。这限制了这些产品的市场,特别是在资源匮乏的环境中,导致感染控制不佳和病患安全风险。製造商可能不愿意为服务不足的市场投资负担得起的系统,这限制了市场成长并抑制创新。
COVID-19 的影响
COVID-19 大流行对探针后处理市场产生了重大影响。随着人们越来越担心防止感染传播,医院和诊所已优先采用自动化、高效的再处理系统,以确保探针的彻底消毒。然而,供应链中断、财务限制以及封锁期间选择性程序的减少阻碍了市场成长。儘管有这些挑战,疫情加速了先进后处理技术的采用,并凸显了严格感染控制的必要性。
预计后处理系统产业在预测期内将是最大的
预计后处理系统领域将在预测期内占据最大的市场占有率。透过提高医疗探头的清洗和消毒效率,医疗机构可以在更短的时间内处理更多的探头。这改善了患者的通透性并降低了营运成本。程序效率的提高和标准化正在推动对这些技术的需求,随着医疗保健提供者寻求简化业务同时遵守严格的感染控制标准,从而导致市场显着增长。
预计手动后处理技术产业在预测期内复合年增长率最高
由于所需的人员和探测时间,医疗机构中的手动再处理是劳力密集且成本高昂的。然而,它们的成本比自动化系统低,这使得它们对预算有限的小型设施具有吸引力。儘管有局限性,但许多设施仍然认为手动再处理是一种实用的解决方案,儘管在大批量处理环境中保持高效率面临挑战。
由于北美对包括探头在内的医疗设备有严格的监管标准,需要彻底的后处理通讯协定,因此预计北美地区将在预测期内占据最大的市场占有率。 FDA、加拿大卫生署和疾病预防控制中心等机构已实施适当清洗、消毒和灭菌的指南。这些法规增加了对可靠、高效的后处理解决方案的需求,导致手动和自动化系统的采用增加。北美的医疗保健组织面临着满足这些严格标准的压力,导致对先进后处理技术(尤其是自动化系统)的需求增加,并推动了市场成长。
亚太地区在日本、韩国和澳洲等已开发国家越来越受欢迎,提供先进的消毒和简化的流程以减少探针花费的时间,预计在预测期内复合年增长率将达到最高。然而,由于预算限制和基础设施问题,印度和中国等新兴市场仍依赖体力劳动。因此,市场是分散的,根据该地区的医疗开发水平,广泛使用手动和自动化技术。
According to Stratistics MRC, the Global Probe Reprocessing Market is accounted for $844.8 million in 2024 and is expected to reach $1712.6 million by 2030 growing at a CAGR of 12.5% during the forecast period. Probe reprocessing is the process of cleaning, disinfecting, and sterilizing medical probes and transducers used in diagnostic imaging procedures, such as ultrasound, to prevent cross-contamination and hospital-acquired infections. This process involves multiple steps, including manual cleaning, high-level disinfection, and sterilization, depending on the risk level. Automated systems are often used to improve efficiency and ensure optimal infection control. The goal is to ensure the safety and integrity of medical probes for repeated use in clinical settings, governed by strict regulatory guidelines and industry standards.
According to data released by MedStar Health in January 2024, over 7 million echocardiograms are conducted annually in the U.S.
Increasing incidence of hospital-acquired infections
The focus on infection control in hospitals and clinics is on preventing healthcare-associated infections (HAIs) caused by improper disinfection or reprocessing of medical equipment like ultrasound probes. As the risk of infection increases, healthcare institutions are adopting specialized, reliable, and effective probe reprocessing technologies to ensure patient safety. This has led to increased demand for advanced cleaning and disinfection systems, boosting the probe reprocessing market.
Lack of knowledge and training
Lack of proper training can lead to manual cleaning errors, resulting in inefficient disinfection and delays in medical probe availability. This can disrupt workflow and increase patient care time. Healthcare facilities may be hesitant to invest in complex reprocessing systems due to workflow inefficiencies, reducing demand for advanced equipment and automated solutions. The perceived complexity of these systems and the challenges posed by insufficient training can create resistance in adopting best practices for probe reprocessing.
Advancements in diagnostic imaging
Diagnostic imaging probes are becoming more sophisticated and delicate, necessitating specialized care for their functionality and accuracy. This has increased pressure on the probe reprocessing market to develop solutions that can preserve these devices' integrity. The market demands specialized and advanced reprocessing equipment to handle intricate cleaning processes, requiring better disinfecting agents, automated cleaning systems, and high-level disinfection solutions. As a result, the demand for specialized and advanced reprocessing equipment is expected to meet the needs of delicate and high-tech probes.
High cost of automated probe reprocessors
Automated probe reprocessing systems require significant initial capital investment, which can be a challenge for smaller hospitals and healthcare centers with limited budgets. The high cost can deter facilities from investing in these technologies, especially when resources are allocated to other essential areas. This restricts the market for these products, especially in low-resource settings, leading to poorer infection control and patient safety risks. This limits market growth and stifles innovation, as manufacturers may be reluctant to invest in affordable systems for underserved markets.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the probe reprocessing market, with the heightened focus on preventing the spread of infections, hospitals and clinics prioritized the adoption of automated and high-efficiency reprocessing systems to ensure thorough disinfection of probes. However, supply chain disruptions, financial constraints, and reduced elective procedures during lockdowns hindered market growth. Despite these challenges, the pandemic accelerated the adoption of advanced reprocessing technologies, emphasizing the need for stringent infection control.
The reprocessing systems segment is expected to be the largest during the forecast period
Over the estimation period, the reprocessing systems segment is expected to capture the largest market share enhance the efficiency of cleaning and disinfecting medical probes, allowing healthcare facilities to process more probes in shorter time. This improves patient throughput and reduces operational costs. The increased efficiency and standardized procedures drive demand for these technologies, leading to a significant growth in the market as healthcare providers seek to streamline operations while adhering to strict infection control standards.
The manual reprocessing technology segment is expected to have the highest CAGR during the forecast period
The manual reprocessing technology segment is expected to have the highest CAGR rate during the estimation period owing to manual reprocessing in healthcare facilities can be labor-intensive and expensive due to the need for staff and probe time. However, it remains lower than automated systems, making it attractive to smaller facilities with limited budgets. Despite its limitations, many facilities still find manual reprocessing a practical solution, despite the challenges it presents in maintaining high efficiency in high-volume environments.
Over the forecasted timeframe, the North America region is anticipated to be the largest market share as North America has strict regulatory standards for medical devices, including probes, requiring thorough reprocessing protocols. Agencies like FDA, Health Canada, and CDC have implemented guidelines for proper cleaning, disinfection, and sterilization. These regulations have driven demand for reliable and efficient reprocessing solutions, leading to increased adoption of manual and automated systems. Healthcare institutions in North America are under pressure to meet these rigorous standards, resulting in increased demand for advanced reprocessing technologies, particularly automated systems, fueling market growth.
The Asia Pacific region is anticipated to witness the highest CAGR growth rate throughout the forecast period owing to gaining popularity in developed countries like Japan, South Korea, and Australia, offering a streamlined process for high disinfection and reduced time spent on probes. However, emerging markets like India and China still rely on manual methods due to budget constraints and infrastructure issues. This creates a segmented market, with both manual and automated technologies being widely used depending on the region's healthcare development level.
Key players in the market
Some of the key players in Probe Reprocessing market include ASP (Fortive Corporation), CIVCO Medical Solutions, CS Medical LLC, Ecolab, GE Healthcare, Germitec, Metrex Research, LLC, Nanosonics, Parker Laboratories Inc, Schulke & Mayr GmbH, Steelco S.p.A., STERIS, Tristel Plc and Virox Technologies Inc.
In December 2024, GE HealthCare unveiled three new advanced deep learning image processing and reconstruction solutions as a part of its Effortless Recon DL portfolio at the Radiological Society of North America (RSNA) 2024 Annual Meeting, in Chicago, IL.
In December 2024, GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd, by purchasing from Sumitomo Chemical the 50% stake it does not already own. As part of GE HealthCare, NMP can build on its expertise developing and manufacturing proprietary and in-licensed radiopharmaceuticals.
In November 2024, Ecolab announced the acquisition of Barclay Water Management, a fast-growing provider of water safety and digital monitoring solutions for industrial and institutional customers based primarily in the northeastern United States.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.